post@lytixbiopharma.com
Aftenposten online writes about Lytix Biopharma's drug candidate LTX-315 and the presentation at AASLD.
http://www.aftenposten.no/helse/Haper-pa-gjennombrudd-for-behandling-av-leverkreft-7361559.html